Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases
Related Experiment Video
Updated: Jun 7, 2026

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
Published on: May 4, 2018
Srinivas Suda1, Alja Westerbeek, Paula M O'Connor
1Department of Microbiology, University College Cork, Cork, Ireland.
Abstract:
Lacticin 3147 is a lantibiotic with seven lanthionine bridges across its two component peptides, Ltnα and Ltnβ. Although it has been proposed that the eponymous lanthionine and (β-methyl)lanthionine (Lan and meLan) bridges present in lantibiotics make an important contribution to protecting the peptides from thermal or proteolytic degradation, few studies have investigated this link. We have generated a bank of bioengineered derivatives of lacticin 3147, in which selected bridges were removed or converted between Lan and meLan, which were exposed to high temperature or proteolytic enzymes. Although switching Lan and meLan bridges has variable consequences, it was consistently observed that an intact N-terminal lanthionine bridge (Ring A) confers Ltnα with enhanced resistance to thermal and proteolytic degradation.
Related Concept Videos
Production of Pharmaceuticals
Microbes in Food Production
Production of Organic Acids
Clinical Significance of Antibiotic Resistance
